Janus Henderson Investors US’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$93.8M Sell
2,991,792
-4,007,136
-57% -$125M 0.08% 293
2016
Q4
$219M Buy
6,998,928
+812,244
+13% +$26.3M 0.18% 159
2016
Q3
$249M Sell
6,186,684
-708,402
-10% -$26.7M 0.21% 134
2016
Q2
$229M Buy
6,895,086
+1,013,364
+17% +$34.7M 0.19% 143
2016
Q1
$173M Buy
5,881,722
+25,626
+0.4% +$707K 0.15% 185
2015
Q4
$154M Sell
5,856,096
-1,536,000
-21% -$39.9M 0.13% 203
2015
Q3
$175M Sell
7,392,096
-2,943,354
-28% -$71M 0.16% 171
2015
Q2
$245M Buy
10,335,450
+1,184,250
+13% +$26.7M 0.2% 126
2015
Q1
$217M Buy
9,151,200
+4,762,800
+109% +$107M 0.18% 152
2014
Q4
$93.2M Buy
4,388,400
+3,636,600
+484% +$73.1M 0.08% 315
2014
Q3
$12.8M Buy
751,800
+608,400
+424% +$9.6M 0.01% 650
2014
Q2
$2.05M Buy
143,400
+58,200
+68% +$789K ﹤0.01% 883
2014
Q1
$1.05M Sell
85,200
-5,400
-6% -$62.3K ﹤0.01% 924
2013
Q4
$993K Sell
90,600
-139,200
-61% -$1.57M ﹤0.01% 928
2013
Q3
$2.67M Sell
229,800
-4,889,100
-96% -$57.2M ﹤0.01% 831
2013
Q2
$57.3M Buy
+5,118,900
New +$60.6M 0.06% 338

Other funds holding EW

Janus Henderson Investors US's EW Position: Q1 2017 in Review

Janus Henderson Investors US reduced its Edwards Lifesciences (EW) stake by 57% in Q1 2017, selling an estimated $125M and leaving 2,991,792 shares worth $93.8M. The position accounts for 0.08% of the portfolio, ranked #293.

Janus Henderson Investors US first reported a position in EW in Q2 2013 and has held it in 16 quarters since. The position peaked at $249M in Q3 2016. 690 funds tracked by Wall St. Rank hold EW as of Q1 2017.

  • Janus Henderson Investors US held 2,991,792 shares of Edwards Lifesciences worth $93.8M as of Q1 2017.
  • Janus Henderson Investors US sold 4,007,136 Edwards Lifesciences shares in Q1 2017, an estimated $125M.
  • Edwards Lifesciences made up 0.08% of Janus Henderson Investors US's portfolio in Q1 2017, its #293 holding.
  • Janus Henderson Investors US first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 16 quarters since.
  • Janus Henderson Investors US's Edwards Lifesciences position peaked at $249M in Q3 2016.
  • 690 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.